Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether weekly paclitaxel followed by weekly
doxorubicin plus daily oral cyclophosphamide without granulocyte colony-stimulating factor
(G-CSF) is feasible in the treatment of locally advanced HER2-negative breast cancer.